BCR-ABL tyrosine kinase inhibitors in the treatment of Philadelphia chromosome positive chronic myeloid leukemia: a review
X An, AK Tiwari, Y Sun, PR Ding, CR Ashby Jr… - Leukemia research, 2010 - Elsevier
Chronic Myeloid Leukemia (CML) is a clonal disease characterized by the presence of the
Philadelphia (Ph+) chromosome and its oncogenic product, BCR-ABL, a constitutively active …
Philadelphia (Ph+) chromosome and its oncogenic product, BCR-ABL, a constitutively active …
BCR-ABL tyrosine kinase inhibitors in the treatment of Philadelphia chromosome positive chronic myeloid leukemia: A review
X An, AK Tiwari, Y Sun, PR Ding, CR Ashby… - Leukemia Research, 2010 - infona.pl
Chronic Myeloid Leukemia (CML) is a clonal disease characterized by the presence of the
Philadelphia (Ph+) chromosome and its oncogenic product, BCR-ABL, a constitutively active …
Philadelphia (Ph+) chromosome and its oncogenic product, BCR-ABL, a constitutively active …
[PDF][PDF] BCR-ABL tyrosine kinase inhibitors in the treatment of Philadelphia chromosome positive chronic myeloid leukemia: A review
X An, AK Tiwari, Y Sun, PR Ding, CR Ashby Jr… - Leukemia …, 2010 - academia.edu
abstract Chronic Myeloid Leukemia (CML) is a clonal disease characterized by the presence
of the Philadelphia (Ph+) chromosome and its oncogenic product, BCR-ABL, a constitutively …
of the Philadelphia (Ph+) chromosome and its oncogenic product, BCR-ABL, a constitutively …
[引用][C] BCR-ABL tyrosine kinase inhibitors in the treatment of Philadelphia chromosome positive chronic myeloid leukemia: A review
X An, AK Tiwari, Y Sun, PR Ding, CR Ashby… - Leukemia Research, 2010 - cir.nii.ac.jp
BCR-ABL tyrosine kinase inhibitors in the treatment of Philadelphia chromosome positive
chronic myeloid leukemia: A review | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ …
chronic myeloid leukemia: A review | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ …
BCR-ABL tyrosine kinase inhibitors in the treatment of Philadelphia chromosome positive chronic myeloid leukemia: a review
X An, AK Tiwari, Y Sun, PR Ding… - Leukemia …, 2010 - pubmed.ncbi.nlm.nih.gov
Chronic Myeloid Leukemia (CML) is a clonal disease characterized by the presence of the
Philadelphia (Ph+) chromosome and its oncogenic product, BCR-ABL, a constitutively active …
Philadelphia (Ph+) chromosome and its oncogenic product, BCR-ABL, a constitutively active …
[PDF][PDF] BCR-ABL tyrosine kinase inhibitors in the treatment of Philadelphia chromosome positive chronic myeloid leukemia: A review
X An, AK Tiwari, Y Sun, PR Ding, CR Ashby Jr… - Leukemia …, 2010 - researchgate.net
abstract Chronic Myeloid Leukemia (CML) is a clonal disease characterized by the presence
of the Philadelphia (Ph+) chromosome and its oncogenic product, BCR-ABL, a constitutively …
of the Philadelphia (Ph+) chromosome and its oncogenic product, BCR-ABL, a constitutively …
BCR-ABL tyrosine kinase inhibitors in the treatment of Philadelphia chromosome positive chronic myeloid leukemia: a review.
X An, AK Tiwari, Y Sun, PR Ding, CR Ashby Jr… - Leukemia …, 2010 - europepmc.org
Chronic Myeloid Leukemia (CML) is a clonal disease characterized by the presence of the
Philadelphia (Ph+) chromosome and its oncogenic product, BCR-ABL, a constitutively active …
Philadelphia (Ph+) chromosome and its oncogenic product, BCR-ABL, a constitutively active …
[PDF][PDF] BCR-ABL tyrosine kinase inhibitors in the treatment of Philadelphia chromosome positive chronic myeloid leukemia: A review
X An, AK Tiwari, Y Sun, PR Ding, CR Ashby Jr… - Leukemia …, 2010 - academia.edu
abstract Chronic Myeloid Leukemia (CML) is a clonal disease characterized by the presence
of the Philadelphia (Ph+) chromosome and its oncogenic product, BCR-ABL, a constitutively …
of the Philadelphia (Ph+) chromosome and its oncogenic product, BCR-ABL, a constitutively …
BCR-ABL tyrosine kinase inhibitors in the treatment of Philadelphia chromosome positive chronic myeloid leukemia: A review
X An, AK Tiwari, Y Sun, PR Ding, CR Ashby… - Leukemia Research, 2010 - infona.pl
Chronic Myeloid Leukemia (CML) is a clonal disease characterized by the presence of the
Philadelphia (Ph+) chromosome and its oncogenic product, BCR-ABL, a constitutively active …
Philadelphia (Ph+) chromosome and its oncogenic product, BCR-ABL, a constitutively active …